2023 Atherosclerosis

2023 动脉粥样硬化

基本信息

批准号：
10675221
负责人：
Filip K Swirski
金额：
$ 0.5万
依托单位：
GORDON RESEARCH CONFERENCES
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-04-01 至 2024-03-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10675221
关键词：
Academia Acceleration Address Animal Model Apolipoproteins B Area Arterial Fatty Streak Arterial Intimas Asia Atherosclerosis Australia Back Behavior Blood Vessels Canada Cardiovascular Diseases Cardiovascular system Cause of Death Cell Nucleus Cell physiology Cells Cessation of life Chronic Collaborations Communication Communities Data Dedications Deposition Developed Countries Development Diabetes Mellitus Disabled Persons Discipline Disease Ensure Environment Equilibrium Europe European Fostering Gender Genetic Genetic Screening Genomics Goals Government Hearing Hematopoiesis Hour Immune Immune system Immunologic Factors Immunologist Incidence Individual Industry Inflammation International Laboratories Learning Life Style Lipids Lipoproteins Machine Learning Mentors Metabolic Molecular Morbidity - disease rate Myocardial Infarction Nerve Degeneration Non-Insulin-Dependent Diabetes Mellitus Obesity Pathologic Pathway interactions Patients Play Postdoctoral Fellow Prevention Productivity Recording of previous events Reporting Research Research Personnel Risk Factors Role Science Scientist Shapes Site Social Interaction South America Spain Stroke Structure Students System Systems Biology Techniques Time Touch sensation Underrepresented Populations United States Vascular Diseases Voice Woman Workplace arterial remodeling career cell type combat commune community building comorbidity design disorder risk diversity and inclusion ezetimibe fighting frontier high dimensionality human model informal atmosphere inhibitor innovation meetings mortality new therapeutic target next generation novel posters prevent programs symposium

项目摘要

Abstract The Gordon Research Conference (GRC) on Atherosclerosis has played a central role in this important field for over 40 years. Although the themes evolve every two years, the format and qualities that make this meeting exceptional are maintained: presentations of cutting-edge unpublished data from leading laboratories within the field and in emerging areas, an environment that encourages open scientific exchange among established and early career investigators from academia, industry and government, and an intimate and inclusive format (<200 attendees) that maximizes productive interactions and discussions between scientists. The goal of the Atherosclerosis GRC conference is to provide a comprehensive overview of research at the cutting edge of the field and the developing frontiers, including the latest and emerging paradigms, the most current techniques for studying atherosclerosis in humans and animal models, and the most promising approaches to prevent and treat cardiovascular disease. The theme of the 2023 meeting is `Molecular mechanisms, genomic modifiers and emerging therapies'. We will: 1) Highlight novel techniques being used to investigate atherosclerosis including high dimensional profiling and spatial organization of vascular and immune cells in the vessel wall, as well as systems biology and machine learning approaches that analyze the atherosclerotic plaque as a whole entity, rather than studying individual cell types as has been done in the past; 2) Discuss new molecular pathways regulating vascular and immune cell function, mechanisms of atherosclerosis regression, immunometabolism, clonal hematopoiesis and genetics of atherosclerosis; 3) Focus on complications of atherosclerosis such as diabetes, myocardial infarction, stroke and neurodegeneration, and 4) Create an inclusive meeting culture that fosters interactions between early and established investigators, welcomes The program will also incorporate short talks and posters from submitted abstracts to capture the latest results and provide ample presentation opportunities for trainees and students. For the first time in 17 years, the Atherosclerosis GRC will be returning to a venue in Europe: the Rey Don Jaime Grand Hotel in Castelldefels, Spain. This site is easily accessed from the United States and Europe (20min from a major airport), and has comprehensive conference facilities, accessible to disabled persons, that accommodate the formal and informal meetings, community meals, and social interactions that make the GRC meetings unique. As the atherosclerosis community is an international group, there has always been strong attendance by our European colleagues of the US-based GRC meetings, and we are excited to bring the meeting closer to them this time. In summary, the Atherosclerosis GRC has been thriving for over 40 years through the support of its strong scientific community and its guiding principles of cutting-edge science, open discussion and inclusion. underrepresented scientists and enables their voices to be heard.